Table 1.
Summary of main limitations to the use of bacteriophages.
Limitation | Description |
---|---|
Phage of Choice | Individual phages are insufficient for broad-spectrum infections; complex identification is needed. Elimination by the reticuloendothelial system reduces half-life, limiting efficacy. |
Lysogenic Forms | Lysogenic phages confer poor results due to acquired immunity. Transduction of bacterial genome and potential transmission of harmful genes are concerns. Using multiple phages is often more effective. |
Legal Limitations | Global regulatory variation in phage utilization. Permitted as a processing aid in certain countries, limited in the EU. |
Purification and Stabilization | Phage characterization is essential for toxicity removal. Purification by ultracentrifugation or chromatography. Stability is crucial but varies among phages. |
Dosage | High phage concentrations are needed for bacterial removal; lower doses are ineffective. Timing and delivery are critical, with potential for induced antibodies. |
Terms of Use | Bacteriophage persistence varies with type, application conditions, and environmental factors. Refrigeration enhances persistence. |
Resistance Mechanisms | Increased phage application may lead to bacterial resistance mechanisms. Coevolution cycles involve various resistance strategies. |
Effectiveness | Efficacy is a major limitation; initial reduction is observed, but complete eradication is challenging. Factors influencing effectiveness include food matrix, pH, temperature, MOI, phagoresistance, and combination with other measures. |